Your session is about to expire
← Back to Search
Nonsteroidal Anti-inflammatory Drug
Intervention with 162 mg aspirin for Prophylaxis of Preeclampsia
Phase 4
Waitlist Available
Research Sponsored by Methodist Medical Center of Illinois
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Any pregnant patient at Peoria FMC
Hx of pre-eclampsia
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, estimated 18 months
Awards & highlights
Study Summary
This is a study to assess if 162 mg of aspirin will decrease rates of preeclampsia in pregnant patients compared to 81 mg of aspirin.
Eligible Conditions
- Prophylaxis of Preeclampsia
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, estimated 18 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, estimated 18 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of participants with eclampsia
Number of participants with preeclampsia
Secondary outcome measures
Number of participants with agranulocytosis
Number of participants with anaphylaxis
Number of participants with aplastic anemia
+2 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Intervention with 162 mg aspirinExperimental Treatment1 Intervention
Aspirin 162 mg daily for prevention of preeclampsia in pregnant patients at Family Medicine Clinic
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Acetylsalicylic acid
FDA approved
Find a Location
Who is running the clinical trial?
University of Illinois College of Medicine at PeoriaOTHER
14 Previous Clinical Trials
11,611 Total Patients Enrolled
UICOM Peoria Family Medicine ResidencyUNKNOWN
Methodist Medical Center of IllinoisLead Sponsor
2 Previous Clinical Trials
95 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger